214 related articles for article (PubMed ID: 15653433)
1. Functional characterization of the postulated intramolecular sphingolipid activator protein domain of human acid sphingomyelinase.
Kölzer M; Ferlinz K; Bartelsen O; Hoops SL; Lang F; Sandhoff K
Biol Chem; 2004 Dec; 385(12):1193-5. PubMed ID: 15653433
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of acid sphingomyelinase activity by lysosomal lipids and sphingolipid activator proteins.
Linke T; Wilkening G; Lansmann S; Moczall H; Bartelsen O; Weisgerber J; Sandhoff K
Biol Chem; 2001 Feb; 382(2):283-90. PubMed ID: 11308026
[TBL] [Abstract][Full Text] [Related]
3. Acid sphingomyelinase possesses a domain homologous to its activator proteins: saposins B and D.
Ponting CP
Protein Sci; 1994 Feb; 3(2):359-61. PubMed ID: 8003971
[TBL] [Abstract][Full Text] [Related]
4. Saposin B mobilizes lipids from cholesterol-poor and bis(monoacylglycero)phosphate-rich membranes at acidic pH. Unglycosylated patient variant saposin B lacks lipid-extraction capacity.
Remmel N; Locatelli-Hoops S; Breiden B; Schwarzmann G; Sandhoff K
FEBS J; 2007 Jul; 274(13):3405-20. PubMed ID: 17561962
[TBL] [Abstract][Full Text] [Related]
5. Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse.
Matsuda J; Kido M; Tadano-Aritomi K; Ishizuka I; Tominaga K; Toida K; Takeda E; Suzuki K; Kuroda Y
Hum Mol Genet; 2004 Nov; 13(21):2709-23. PubMed ID: 15345707
[TBL] [Abstract][Full Text] [Related]
6. Characterization of human saposins by NMR spectroscopy.
John M; Wendeler M; Heller M; Sandhoff K; Kessler H
Biochemistry; 2006 Apr; 45(16):5206-16. PubMed ID: 16618109
[TBL] [Abstract][Full Text] [Related]
7. Fusogenic domain and lysines in saposin C.
Qi X; Chu Z
Arch Biochem Biophys; 2004 Apr; 424(2):210-8. PubMed ID: 15047193
[TBL] [Abstract][Full Text] [Related]
8. An Asn > Lys substitution in saposin B involving a conserved amino acidic residue and leading to the loss of the single N-glycosylation site in a patient with metachromatic leukodystrophy and normal arylsulphatase A activity.
Regis S; Filocamo M; Corsolini F; Caroli F; Keulemans JL; van Diggelen OP; Gatti R
Eur J Hum Genet; 1999; 7(2):125-30. PubMed ID: 10196694
[TBL] [Abstract][Full Text] [Related]
9. Effect of saposins on acid sphingomyelinase.
Tayama M; Soeda S; Kishimoto Y; Martin BM; Callahan JW; Hiraiwa M; O'Brien JS
Biochem J; 1993 Mar; 290 ( Pt 2)(Pt 2):401-4. PubMed ID: 8452527
[TBL] [Abstract][Full Text] [Related]
10. Conformational and amino acid residue requirements for the saposin C neuritogenic effect.
Qi X; Kondoh K; Krusling D; Kelso GJ; Leonova T; Grabowski GA
Biochemistry; 1999 May; 38(19):6284-91. PubMed ID: 10320358
[TBL] [Abstract][Full Text] [Related]
11. A mutation in the saposin C domain of the sphingolipid activator protein (Prosaposin) gene causes neurodegenerative disease in mice.
Yoneshige A; Suzuki K; Suzuki K; Matsuda J
J Neurosci Res; 2010 Aug; 88(10):2118-34. PubMed ID: 20175216
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of lysosomal sphingomyelin degradation by sphingolipid activator proteins.
Ferlinz K; Linke T; Bartelsen O; Weiler M; Sandhoff K
Chem Phys Lipids; 1999 Nov; 102(1-2):35-43. PubMed ID: 11001559
[TBL] [Abstract][Full Text] [Related]
13. Structure of Human Acid Sphingomyelinase Reveals the Role of the Saposin Domain in Activating Substrate Hydrolysis.
Xiong ZJ; Huang J; Poda G; Pomès R; Privé GG
J Mol Biol; 2016 Jul; 428(15):3026-42. PubMed ID: 27349982
[TBL] [Abstract][Full Text] [Related]
14. The N370S (Asn370-->Ser) mutation affects the capacity of glucosylceramidase to interact with anionic phospholipid-containing membranes and saposin C.
Salvioli R; Tatti M; Scarpa S; Moavero SM; Ciaffoni F; Felicetti F; Kaneski CR; Brady RO; Vaccaro AM
Biochem J; 2005 Aug; 390(Pt 1):95-103. PubMed ID: 15826241
[TBL] [Abstract][Full Text] [Related]
15. Structures of the human ceramide activator protein saposin D.
Popovic K; Privé GG
Acta Crystallogr D Biol Crystallogr; 2008 May; 64(Pt 5):589-94. PubMed ID: 18453694
[TBL] [Abstract][Full Text] [Related]
16. An Early-Onset Neuronopathic Form of Acid Sphingomyelinase Deficiency: A SMPD1 p.C133Y Mutation in the Saposin Domain of Acid Sphingomyelinase.
Ota S; Noguchi A; Kondo D; Nakajima Y; Ito T; Arai H; Takahashi T
Tohoku J Exp Med; 2020 Jan; 250(1):5-11. PubMed ID: 31941852
[TBL] [Abstract][Full Text] [Related]
17. The saposin-like proteins 1, 2, and 3 of Fasciola gigantica.
Grams R; Adisakwattana P; Ritthisunthorn N; Eursitthichai V; Vichasri-Grams S; Viyanant V
Mol Biochem Parasitol; 2006 Aug; 148(2):133-43. PubMed ID: 16626816
[TBL] [Abstract][Full Text] [Related]
18. Solution structure of human saposin C in a detergent environment.
Hawkins CA; de Alba E; Tjandra N
J Mol Biol; 2005 Mar; 346(5):1381-92. PubMed ID: 15713488
[TBL] [Abstract][Full Text] [Related]
19. A novel saposin-like protein of Entamoeba histolytica with membrane-fusogenic activity.
Winkelmann J; Leippe M; Bruhn H
Mol Biochem Parasitol; 2006 May; 147(1):85-94. PubMed ID: 16529828
[TBL] [Abstract][Full Text] [Related]
20. Direct visualization of saposin remodelling of lipid bilayers.
Alattia JR; Shaw JE; Yip CM; Privé GG
J Mol Biol; 2006 Oct; 362(5):943-53. PubMed ID: 16949605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
